UROV - Urovant Sciences' (UROV) CEO Keith Katkin on Q3 2019 Results - Earnings Call Transcript
Urovant Sciences Ltd. (UROV)
Q3 2019 Earnings Conference Call
February 13, 2020 5:00 PM ET
Company Participants
Ryan Kubota – Executive Director of IR
Keith Katkin – Chief Executive Officer
Ajay Bansal – Chief Financial Officer
Cornelia Haag-Molkenteller – Chief Medical Officer
Conference Call Participants
Eric Joseph – JP Morgan
Edward Marks – H.C. Wainwright
Biren Amin – Jefferies
Presentation
Operator
Good day, ladies and gentlemen, and welcome to Urovant Fiscal Third Quarter 2019 Earnings Call. At this time all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions